Circular regarding (1) the proposed rights issue based on a ratio of three rights shares for every two shares held as of the record date; (2) the related transaction involving the underwriting agreement; (3) the application for a cleansing waiver; and (4) the special transaction.
Notice of the Special General Meeting
Letter of Appointment as Representative
Change of Date for the 2023 Annual General Meeting of Shareholders and Extension of the Suspension Period for Share Transfer Registration Procedures
Delayed issuance of the circular regarding (1) the proposed rights issue based on a ratio of 3 rights shares for every 2 shares held as of the record date; (2) the related transaction involving the underwriting agreement; (3) the application for a cleansing waiver; and (4) the special transaction, along with the revised timetable.
Delayed issuance of the circular regarding (1) the proposed rights issue based on a ratio of 3 rights shares for every 2 shares held as of the record date; (2) the related transaction involving the underwriting agreement; (3) the application for a cleansing waiver; and (4) the special transaction.
Monthly Statement of Securities Transactions by the Share Issuer as of March 31, 2023
Full-Year Results Announcement for the Year Ended December 31, 2022
Change the Board Meeting Date
(1) It is recommended to conduct a rights issue on the basis of three (3) rights shares being allotted for every two (2) shares held as of the record date; (2) Related transactions concerning the underwriting agreement; (3) Application for a cleansing waiver; (4) Special transaction; and (5) Resumption of trading
Change the Board Meeting Date
Brief Trading Halt
Profit Warning
Board Meeting Notice
Monthly Report on Securities Transactions of the Share Issuer as of February 28, 2023
Monthly Statement of Securities Transactions by the Share Issuer as of January 31, 2023
Monthly Statement of Securities Transactions by the Share Issuer as of December 31, 2022